CrossrefInfokarte
Accelerating drug discovery targeting KRAS mutations with advanced high-throughput hit identification technologies
Current Molecular Pharmacology · 2026 · 19 (1) · 225-227
DOI: 10.1016/j.cmp.2026.09.002 ↗Abstract
Kein Abstract verfügbar.
EUVIMED